Modelled Public Health Impact of Introducing Adjuvanted Recombinant Zoster Vaccine into the UK National Immunisation Programme
Sign Up to like & getrecommendations! Published in 2024 at "Infectious Diseases and Therapy"
DOI: 10.1007/s40121-024-01073-3
Abstract: Introduction In 2023, recombinant zoster vaccine (RZV) replaced zoster vaccine live (ZVL) vaccine in the UK National Immunisation Programme (NIP) for prevention of herpes zoster (HZ). The vaccination age was reduced from 70 to 65… read more here.
Keywords: zoster vaccine; health; vaccination; rzv vaccination ... See more keywords
Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials
Sign Up to like & getrecommendations! Published in 2021 at "Drug Safety"
DOI: 10.1007/s40264-021-01076-w
Abstract: The adjuvanted recombinant zoster vaccine (RZV) has demonstrated high efficacy against herpes zoster in older adults and immunocompromised populations. We present comprehensive safety data from six clinical trials in immunocompromised populations (autologous hematopoietic stem cell… read more here.
Keywords: zoster vaccine; safety; herpes zoster; recombinant zoster ... See more keywords
Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine.
Sign Up to like & getrecommendations! Published in 2019 at "Current opinion in immunology"
DOI: 10.1016/j.coi.2019.02.009
Abstract: Herpes zoster is common in older and immune suppressed persons due to diminished VZV-specific cellular immunity. A recombinant herpes zoster vaccine (RZV) consisting of a single VZV glycoprotein and an adjuvant system stimulates robust and… read more here.
Keywords: zoster vaccine; herpes zoster; glycoprotein; immunology ... See more keywords
Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States.
Sign Up to like & getrecommendations! Published in 2021 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2021.04.017
Abstract: PURPOSE To examine the effectiveness of the recombinant zoster vaccine for preventing herpes zoster ophthalmicus in the general US population. DESIGN Retrospective, observational cohort study. PARTICIPANTS Individuals enrolled in the OptumLabs® Data Warehouse (OLDW) (OptumLabs,… read more here.
Keywords: zoster vaccine; recombinant zoster; herpes zoster; zoster ophthalmicus ... See more keywords
Determining the optimal strategy for the live-attenuated herpes zoster vaccine in adults.
Sign Up to like & getrecommendations! Published in 2018 at "Vaccine"
DOI: 10.1016/j.vaccine.2018.06.059
Abstract: The optimal strategy for the vaccinating against herpes zoster (HZ) vaccine remains unknown. Cost-effectiveness analyses provide insight to the most cost-effective age groups but results vary across studies. The optimal strategy is important given that… read more here.
Keywords: zoster vaccine; age; herpes zoster; optimal strategy ... See more keywords
Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.
Sign Up to like & getrecommendations! Published in 2018 at "Vaccine"
DOI: 10.1016/j.vaccine.2018.08.037
Abstract: BACKGROUND Herpes zoster (shingles) is a common viral disease increasing in risk and severity with age. Post-herpetic neuralgia (PHN), a complication of shingles, causes severe pain impacting quality of life (QoL). Zoster Vaccine Live (ZVL),… read more here.
Keywords: vaccine live; risk; zoster vaccine; united kingdom ... See more keywords
A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Epidemiology"
DOI: 10.1093/aje/kwac030
Abstract: Abstract The recombinant herpes zoster vaccine (RZV), approved as a 2-dose series in the United States in October 2017, has proven highly effective and generally safe. However, a small risk of Guillain-Barré syndrome after vaccination… read more here.
Keywords: safety; recombinant herpes; zoster vaccine; herpes zoster ... See more keywords
P0845 Safety and Adverse Events of the Adjuvanted Herpes Zoster Vaccine (Shingrix) in Inflammatory Bowel Disease Patients: A Comparison of Age Groups Under and Over 50 Years
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjae190.1019
Abstract: This study investigates the safety profile of the adjuvanted herpes zoster (HZ) vaccine (Shingrix) in patients with inflammatory bowel disease (IBD), particularly comparing adverse events (AEs) in those under 50 years old versus those 50… read more here.
Keywords: age; disease; herpes zoster; zoster vaccine ... See more keywords
Improving herpes zoster vaccine rates: The impact of a targeted educational program
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American Association of Nurse Practitioners"
DOI: 10.1097/jxx.0000000000000039
Abstract: Background and purpose: Despite demonstrated efficacy, the utilization of herpes zoster vaccine (HZV), recommended by the Centers for Disease Control (CDC) for all immunocompetent adults aged above 60 years, is low (31%). The aim of… read more here.
Keywords: zoster vaccine; hzv; herpes zoster; program ... See more keywords
Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares.
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the rheumatic diseases"
DOI: 10.1136/annrheumdis-2019-216639
Abstract: We have read with great interest the article addressing the risk of gout flares after vaccination in a case crossover study by Yokose et al .1 The authors suggest that vaccines may be associated with… read more here.
Keywords: zoster vaccine; gout flares; recombinant zoster; gout ... See more keywords
Public health impact model estimating the impact of introducing an adjuvanted recombinant zoster vaccine into the UK universal mass vaccination programme
Sign Up to like & getrecommendations! Published in 2019 at "BMJ Open"
DOI: 10.1136/bmjopen-2018-025553
Abstract: Objectives In 2013, the herpes zoster (HZ) immunisation programme was introduced in the UK, recommending vaccination of adults 70 years of age (YOA) with the zoster vaccine live (ZVL), the only vaccine available at the… read more here.
Keywords: zoster vaccine; vaccine; impact; health ... See more keywords